Clinical trials
Phase 4 Essential Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 6 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Unknown status | 15 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 4 |
| University of Pavia | 3 |
| Chong Kun Dang Pharmaceutical | 2 |
| GlaxoSmithKline | 2 |
| Organon and Co | 2 |
| Radboud University Medical Center | 2 |
| Shanghai Shyndec Pharmaceutical Co., Ltd. | 2 |
| University of Athens | 2 |
| Aarhus University Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 60 |
| Hypertension | 20 |
| Diabetes Mellitus, Type 2 | 5 |
| Cardiovascular Diseases | 3 |
| Stroke | 2 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Diabetic Nephropathies | 1 |
| Fatty Liver | 1 |
| Heart Failure | 1 |
Trials
Showing 76 to 60 of 60. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.